Tokyo, Aug. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058864) titled 'Risk Factors and Clinical Outcomes of Hypo-attenuated Leaflet Thickening (HALT) After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis' on Aug. 22.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Department of Diagnostic Radiology, Yokohama City University Graduate School of Medicine
Condition:
Condition - patients who underwent transcatheter aortic valve replacement (TAVR)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate risk factors for the occurrence of hypo-attenuated leaflet thickening (HALT) after transcatheter aortic valve replacement (TAVR) and to evaluate the impact of HALT on clinical outcomes.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1.Studies including patients with aortic stenosis who underwent transcatheter aortic valve replacement (TAVR).
2.Studies evaluating the incidence (number of events) of hypo-attenuated leaflet thickening (HALT) and clinical outcomes.
3.Eligible study designs: retrospective and prospective observational studies, and randomized controlled trials (RCTs).
Key exclusion criteria - We excluded case reports, case series, animal studies
Recruitment Status:
Recruitment status - Open public recruiting
Date of protocol fixation - 2025 Year 04 Month 01 Day
Date of IRB - 2025 Year 04 Month 01 Day
Anticipated trial start date - 2025 Year 04 Month 01 Day
Last follow-up date - 2025 Year 08 Month 22 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067315
Disclaimer: Curated by HT Syndication.
